Want to see HK:1332 full AI Analyst Report?
1332 Stock Chart & Stats
HK$0.21
<HK$0.01(2.59%)
At close: 4:00 PM EST
HK$0.21
<HK$0.01(2.59%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.75
Previous CloseN/A
Volume50.63K
Average Volume (3M)711.77K
Market Cap
HK$392.83M
Enterprise ValueHK$759.26M
Total Cash (Recent Filing)HK$5.06M
Total Debt (Recent Filing)HK$413.62M
Price to Earnings (P/E)32.6
Beta-0.20
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,805,952,100
10 Day Avg. Volume262,687
30 Day Avg. Volume711,770
Financial Highlights & Ratios
PEG Ratio-1.74
Price to Book (P/B)-29.02
Price to Sales (P/S)22.14
P/FCF Ratio-45.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Narrowing Free Cash Flow LossA reduced free cash flow shortfall in 2025 versus 2024 signals the company is beginning to stem cash outflows. If sustained, this durable trend can lower near-term financing needs, improve liquidity flexibility and provide runway for restructuring or operational fixes over the next several quarters.
Reported Net Income Turned Positive (2025)A positive reported net income in 2025, even if partly non-operating, creates a base to rebuild retained earnings and creditor confidence. Over 2-6 months this can materially help capital structure discussions, support debt negotiations and fund targeted recovery actions if management can convert this into recurring operating improvement.
Prior Periods Showed Healthier CapitalizationHistorical positive equity and manageable leverage indicate the business has previously supported a healthier capital structure. That track record suggests the underlying business model can generate sufficient returns under better conditions, supporting plausibility of a multi-quarter recovery or viable restructuring plan.
Bears Say
Negative Shareholders' EquitySustained negative shareholders' equity is a structural solvency red flag that limits the company's financial flexibility. It impairs ability to absorb losses, restricts access to capital markets, raises refinancing and covenant risks, and elevates the probability of restructuring over a multi-quarter horizon.
Severe Revenue ContractionA 42.9% year-over-year revenue decline in 2025 reflects durable loss of scale and demand. Reduced topline undermines fixed-cost absorption and margin sustainability, making near-term operating recovery more difficult and increasing the likelihood that revenue trends will pressure cash flow and profitability for several quarters.
Persistently Negative Operating Cash FlowConsistent negative operating and free cash flow means the business is structurally consuming cash, requiring ongoing external funding or asset disposals. This persistent cash burn increases refinancing risk, potential dilution, and limits reinvestment ability over a sustained 2-6 month period absent operational turnaround.
China Touyun Tech Group News
1332 FAQ
What was China Touyun Tech Group Ltd’s price range in the past 12 months?
China Touyun Tech Group Ltd lowest stock price was HK$0.07 and its highest was HK$0.75 in the past 12 months.
What is China Touyun Tech Group Ltd’s market cap?
China Touyun Tech Group Ltd’s market cap is HK$392.83M.
When is China Touyun Tech Group Ltd’s upcoming earnings report date?
China Touyun Tech Group Ltd’s upcoming earnings report date is Aug 21, 2026 which is in 14 days.
How were China Touyun Tech Group Ltd’s earnings last quarter?
China Touyun Tech Group Ltd released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.003.
Is China Touyun Tech Group Ltd overvalued?
According to Wall Street analysts China Touyun Tech Group Ltd’s price is currently Overvalued.
Does China Touyun Tech Group Ltd pay dividends?
China Touyun Tech Group Ltd does not currently pay dividends.
What is China Touyun Tech Group Ltd’s EPS estimate?
China Touyun Tech Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Touyun Tech Group Ltd have?
China Touyun Tech Group Ltd has 2,805,952,100 shares outstanding.
What happened to China Touyun Tech Group Ltd’s price movement after its last earnings report?
China Touyun Tech Group Ltd reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.444%.
Which hedge fund is a major shareholder of China Touyun Tech Group Ltd?
Currently, no hedge funds are holding shares in HK:1332
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Touyun Tech Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.20%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.61%
Trailing 12-Months
Company Description
China Touyun Tech Group Ltd
Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.
Technical Analysis
Greatview Aseptic Packaging Company
―
Singamas Container Holdings
―
Pacific Millennium Packaging Group Corp.
―
China Aluminum Cans Holdings Ltd.
―
Wan Cheng Metal Packaging Company Limited
―